The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
Tracing the development of psychosis and its prevention: What can be learned from animal models
Abstract
Schizophrenia (SCZ) is a neurodevelopmental disorder manifested symptomatically after puberty whose pharmacotherapy remains unsatisfactory. In recent years, longitudinal structural neuroimaging studies have revealed that neuroanatomical aberrations occur in this disorder and in fact precede symptom onset, raising the exciting possibility that SCZ can be prevented. There is some evidence that treatment with atypical antipsychotic drugs (APDs) prior to the development of the full clinical phenotype reduces the risk of transition to psychosis, but results remain controversial. It remains unknown whether progressive structural brain aberrations can be halted. Given the diagnostic, ethical, clinical and methodological problems of pharmacological and imaging studies in patients, getting such information remains a major challenge. Animal neurodevelopmental models of SCZ are invaluable for investigating such questions because they capture the notion that the effects of early brain damage are progressive. In recent years, data derived from such models have converged on key neuropathological and behavioral deficits documented in SCZ attesting to their strong validity, and making them ideal tools for evaluating progression of pathology following in-utero insults as well as its prevention. We review here our recent studies that use longitudinal in vivo structural imaging to achieve this aim in the prenatal immune stimulation model that is based on the association of prenatal infection and increased risk for SCZ. Pregnant rats were injected on gestational day 15 with the viral mimic polyriboinosinic-polyribocytidylic acid (poly I:C) or saline. Male and female offspring were imaged and tested behaviorally on postnatal days (PNDs) 35, 46, 56, 70 and 90. In other experiments, offspring of poly I:C- and saline-treated dams received the atypical antipsychotic drugs (APDs) clozapine or risperidone in two developmental windows: PND 34-47 and PND 48-61, and underwent behavioral testing and imaging at adulthood. Prenatal poly I:C-induced interference with fetal brain development led to aberrant postnatal brain development as manifested in structural abnormalities in the hippocampus, the striatum, the prefrontal cortex and lateral ventricles (LV), as seen in SCZ. The specific trajectories were region-, age- and sex-specific, with females having delayed onset of pathology compared to males. Brain pathology was accompanied by development of behavioral abnormalities phenotypic of SCZ, attentional deficit and hypersensitivity to amphetamine, with same sex difference. Hippocampal volume loss and LV volume expansion as well as behavioral abnormalities were prevented in the offspring of poly I:C mothers who received clozapine or risperidone during the asymptomatic period of adolescence (PND 34-47). Administration at a later window, PNDs 48-61, exerted sex-, region- and drug- specific effects. Our data show that prenatal insult leads to progressive postnatal brain pathology, which gradually gives rise to "symptoms"; that treatment with atypical APDs can prevent both brain and behavioral pathology; and that the earlier the intervention, the more pathological outcomes can be prevented.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and reduced the volume of the hippocampus in adult mice.”
From Neuroinflammation as a risk factor for attention deficit hyperactivity disorder (2019) · cites this paper as Piontkewitz et al., 2012
In the citing paper
“Prenatal exposure to poly(I:C) (Piontkewitz et al., 2012) reduced the volume of the prefrontal cortex”
From Neuroinflammation as a risk factor for attention deficit hyperactivity disorder (2019) · cites this paper as Piontkewitz et al., 2012
Citations
Cites
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
The adolescent brain and age-related behavioral manifestations
Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Kapur, S. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.13 · Cited by 2,813
Synaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Mapping cortical change across the human life span
Sowell, E. R., Peterson, B. S., Thompson, P. M., Welcome, S. E., Henkenius, A. L., & Toga, A. W. (2003) · Nature Neuroscience · doi:10.1038/nn1008 · Cited by 2,328
Cited by
Sorted by citations
Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems
Meyer, U. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.07.011 · Cited by 626
Immune–neural connections: how the immune system’s response to infectious agents influences behavior
McCusker, R. H., & Kelley, K. W. (2013) · Journal of Experimental Biology · doi:10.1242/jeb.073411 · Cited by 429
Millan, M. J., Fone, K. C. F., Steckler, T., & Horan, W. P. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.008 · Cited by 376
Maternal immune activation and autism spectrum disorder: From rodents to nonhuman and human primates
Careaga, M., Murai, T., & Bauman, M. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.020 · Cited by 348
Neuroinflammation as a risk factor for attention deficit hyperactivity disorder
Dunn, G. A., Nigg, J. T., & Sullivan, E. L. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.05.005 · Cited by 299
Kentner, A. C., Bilbo, S. D., Brown, A. S., Hsiao, E. Y., McAllister, A. K., Meyer, U., Pearce, B. D., Pletnikov, M. V., Yolken, R. H., & Bauman, M. D. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0185-7 · Cited by 259
An Overview of Animal Models Related to Schizophrenia
Winship, I. R., Dursun, S. M., Baker, G. B., Balista, P. A., Kandratavicius, L., Maia‐de‐Oliveira, J. P., Hallak, J. E. C., & Howland, J. G. (2018) · The Canadian Journal of Psychiatry · doi:10.1177/0706743718773728 · Cited by 263
Reisinger, S. N., Khan, D., Kong, E., Berger, A., Pollak, A. J., & Pollak, D. D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.001 · Cited by 238
Mattei, D., Djodari-Irani, A., Hadar, R., Pelz, A., de Cossío, L. F., Goetz, T., Matyash, M., Kettenmann, H., Winter, C., & Wolf, S. A. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.01.019 · Cited by 195
Do, K. Q., Cuenod, M., & Hensch, T. K. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv065 · Cited by 158
Viral infection, inflammation and schizophrenia
Kneeland, R. E., & Fatemi, S. H. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.001 · Cited by 152
Lipina, T. V., Zai, C. C. H., Hlousek, D., Roder, J., & Wong, A. H. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0091-13.2013 · Cited by 156
Giovanoli, S., Weber‐Stadlbauer, U., Schedlowski, M., Meyer, U., & Engler, H. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.015 · Cited by 139
Robicsek, O., Ene, H. M., Karry, R., Ytzhaki, O., Asor, E., McPhie, D. L., Cohen, B. M., Ben-Yehuda, R., Weiner, I., & Ben‐Shachar, D. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx077 · Cited by 135
Self-citationHowland, J. G., Cazakoff, B. N., & Zhang, Y. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.011 · Cited by 127
Gomes, F. V., Rincón‐Cortés, M., & Grace, A. A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.05.030 · Cited by 131
Maternal immune activation, central nervous system development and behavioral phenotypes
Minakova, E., & Warner, B. B. (2018) · Birth Defects Research · doi:10.1002/bdr2.1416 · Cited by 114
Weir, R. K., Forghany, R., Smith, S. E. P., Patterson, P. H., McAllister, A. K., Schumann, C. M., & Bauman, M. D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.03.009 · Cited by 86
Paylor, J. W., Lins, B. R., Greba, Q., Moen, N., de Moraes, R. S., Howland, J. G., & Winship, I. R. (2016) · Scientific Reports · doi:10.1038/srep37580 · Cited by 80
Hollins, S. L., Zavitsanou, K., Walker, F. R., & Cairns, M. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.99 · Cited by 82
Crum, W. R., Sawiak, S. J., Chege, W., Cooper, J. D., Williams, S. C. R., & Vernon, A. C. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.008 · Cited by 76
Guma, E., Bordignon, P. D. C., Devenyi, G. A., Gallino, D., Anastassiadis, C., Cvetkovska, V., Barry, A., Snook, E., Germann, J., Greenwood, C. M. T., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.03.017 · Cited by 73
Hadar, R., Soto‐Montenegro, M. L., Götz, T., Wieske, F., Sohr, R., Desco, M., Hamani, C., Weiner, I., Pascau, J., & Winter, C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.05.010 · Cited by 74
Self-citationBallendine, S. A., Greba, Q., Dawicki, W., Zhang, X., Gordon, J., & Howland, J. G. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.11.002 · Cited by 70
Vlasova, R., Iosif, A., Ryan, A. M., Funk, L. H., Murai, T., Chen, S., Lesh, T. A., Rowland, D. J., Bennett, J., Hogrefe, C. E., et al. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0378-21.2021 · Cited by 70
Bauman, M. D., & de Water, J. V. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104864 · Cited by 65
Systemic maternal inflammation promotes ASD via IL-6 and IFN-γ
Majerczyk, D., Ayad, E., Brewton, K. L., Saing, P., & Hart, P. C. (2022) · Bioscience Reports · doi:10.1042/bsr20220713 · Cited by 63
Bikovski, L., Hadar, R., Soto‐Montenegro, M. L., Klein, J., Weiner, I., Desco, M., Pascau, J., Winter, C., & Hamani, C. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.012 · Cited by 64
Self-citationMartino, D., Johnson, I. N. S., & Leckman, J. F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.567407 · Cited by 60
Lins, B. R., Hurtubise, J. L., Roebuck, A. J., Marks, W. N., Zabder, N. K., Scott, G. A., Greba, Q., Dawicki, W., Zhang, X., Rudulier, C. D., et al. (2018) · eNeuro · doi:10.1523/eneuro.0249-18.2018 · Cited by 62
Milstein, J. A., Elnabawi, A., Vinish, M., Swanson, T., Enos, J. K., Bailey, A. M., Kolb, B., & Frost, D. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057308 · Cited by 57
Tandon, N., Shah, J. L., Keshavan, M. S., & Tandon, R. (2012) · Neuropsychiatry · doi:10.2217/npy.12.36 · Cited by 60
Gestational cytokine concentrations and neurocognitive development at 7 years
Ghassabian, A., Albert, P. S., Hornig, M., Yeung, E. H., Cherkerzian, S., Goldstein, R. B., Buka, S. L., Goldstein, J. M., & Gilman, S. E. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0112-z · Cited by 56
Patrich, E., Piontkewitz, Y., Peretz, A. S., Weiner, I., & Attali, B. (2016) · Scientific Reports · doi:10.1038/srep19106 · Cited by 59
Self-citationMaternal immune activation during pregnancy in rats impairs working memory capacity of the offspring
Murray, B. G., Davies, D. A., Molder, J. J., & Howland, J. G. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.04.005 · Cited by 55
Careaga, M., Taylor, S. L., Chang, C., Chiang, A., Ku, K. M., Berman, R. F., de Water, J. V., & Bauman, M. D. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.014 · Cited by 53
da Silveira, V. T., de Castro Medeiros, D., Ropke, J., Guidine, P. A., Rezende, G. H., Moraes, M. F. D., Mendes, E. M. A. M., Macedo, D., Moreira, F. A., & de Oliveira, A. C. P. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.01.009 · Cited by 51
Li, M. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116654697 · Cited by 51
Hadar, R., Dong, L., Del-Valle-Anton, L., Güneykaya, D., Voget, M., Edemann-Callesen, H., Schweibold, R., Djodari-Irani, A., Goetz, T., Ewing, S. G., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.003 · Cited by 56
Lins, B. R., Marks, W. N., Zabder, N. K., Greba, Q., & Howland, J. G. (2019) · eNeuro · doi:10.1523/eneuro.0437-18.2019 · Cited by 54
Graham, A. M., Doyle, O. J., Tilden, E. L., Sullivan, E. L., Gustafsson, H., Marr, M. C., Allen, M. C., & Seghete, K. L. M. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.10.012 · Cited by 56
Ding, S., Hu, Y., Luo, B., Cai, Y., Hao, K., Yang, Y., Zhang, Y., Wang, X., Ding, M., Zhang, H., et al. (2019) · Behavioral and Brain Functions · doi:10.1186/s12993-019-0154-2 · Cited by 48
Zavitsanou, K., Lim, C. K., Purves-Tyson, T., Karl, T., Kassiou, M., Banister, S. D., Guillemin, G. J., & Weickert, C. S. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.05.011 · Cited by 46
Hadar, R., Bikovski, L., Soto‐Montenegro, M. L., Schimke, J., Maier, P., Ewing, S. G., Voget, M., Wieske, F., Götz, T., Desco, M., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.52 · Cited by 49
Self-citationHoriguchi, M., Hannaway, K. E., Adelekun, A. E., Jayathilake, K., & Meltzer, H. Y. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.64 · Cited by 45
Kesby, J. P., Cui, X., Burne, T. H. J., & Eyles, D. W. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00111 · Cited by 45
Guma, E., Bordeleau, M., Ibáñez, F. G., Picard, K., Snook, E., Desrosiers-Grégoire, G., Spring, S., Lerch, J. P., Nieman, B. J., Devenyi, G. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2114545119 · Cited by 42
Biase, M. A. D., Katabi, G., Piontkewitz, Y., Karayumak, S. C., Weiner, I., & Pasternak, O. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.010 · Cited by 41
Self-citationBauman, M. D., Lesh, T. A., Rowland, D. J., Schumann, C. M., Smucny, J., Kukis, D. L., Cherry, S. R., McAllister, A. K., & Carter, C. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0449-y · Cited by 43
Pre-clinical models of neurodevelopmental disorders: focus on the cerebellum
Shevelkin, A. V., Ihenatu, C., & Pletnikov, M. V. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0049 · Cited by 42
Behavioral Animal Models of Antipsychotic Drug Actions
Peleg‐Raibstein, D., Feldon, J., & Meyer, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_14 · Cited by 39
Stress, depression, and hippocampus: from biochemistry to electrophysiology
Idunkova, A., Lacinová, Ľ., & Hoppanová, L. (2023) · General Physiology and Biophysics · doi:10.4149/gpb_2023001 · Cited by 36
Vernon, A. C., So, P., Lythgoe, D. J., Chege, W., Cooper, J. D., Williams, S., & Kapur, S. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.022 · Cited by 36
Hanson, K. L., Grant, S. E., Funk, L. H., Schumann, C. M., & Bauman, M. D. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.004 · Cited by 34
Animal Models of Schizophrenia
Yanagi, M., Southcott, S. A., Lister, J. M., & Tamminga, C. A. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394596-9.00012-3 · Cited by 32
Sangha, S., Greba, Q., Robinson, P., Ballendine, S., & Howland, J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00168 · Cited by 33
Guma, E., Cupo, L., Ma, W., Gallino, D., Moquin, L., Gratton, A. P., Devenyi, G. A., & Chakravarty, M. M. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110642 · Cited by 32
Hollins, S. L., Zavitsanou, K., Walker, F. R., & Cairns, M. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.02.021 · Cited by 30
Astrocytes as Pharmacological Targets in the Treatment of Schizophrenia
Pocivavsek, A., Notarangelo, F. M., Wu, H., Bruno, J. P., & Schwarcz, R. M. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00025-0 · Cited by 30
Zhang, J., Yu, J., Zhang, H., Bilkey, D. K., & Liu, P. (2018) · Synapse · doi:10.1002/syn.22072 · Cited by 27
Li, Y., Dugyala, S., Ptacek, T., Gilmore, J. H., & Frӧhlich, F. (2018) · eNeuro · doi:10.1523/eneuro.0313-18.2018 · Cited by 27
Lins, B. R., Pushie, M. J., Jones, M. W., Howard, D. L., Howland, J. G., & Hackett, M. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158152 · Cited by 27
Deane, A. R., Millar, J., Bilkey, D. K., & Ward, R. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187719 · Cited by 28
Richtand, N. M., Ahlbrand, R., Horn, P. S., Tambyraja, R., Grainger, M., Bronson, S. L., & McNamara, R. K. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.02.004 · Cited by 24
Chou, S., Jones, S., & Li, M. (2015) · Brain Research · doi:10.1016/j.brainres.2015.05.036 · Cited by 23
Casquero‐Veiga, M., Romero‐Miguel, D., MacDowell, K. S., Torres-Sánchez, S., Garcia-Partida, J. A., Lamanna‐Rama, N., Gómez‐Rangel, V., Romero‐Miranda, A., Berrocoso, E., Leza, J. C., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.02.001 · Cited by 22
Patrich, E., Piontkewitz, Y., Peretz, A. S., Weiner, I., & Attali, B. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.08.021 · Cited by 27
Self-citationSexual dimorphism of the cerebellar vermis in schizophrenia
Womer, F. Y., Tang, Y., Harms, M. P., Bai, C., Chang, M., Jiang, X., Wei, S., Wang, F., & Barch, D. M. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.06.028 · Cited by 23
Human latent inhibition: Problems with the stimulus exposure effect
Byrom, N., Msetfi, R. M., & Murphy, R. A. (2018) · Psychonomic Bulletin & Review · doi:10.3758/s13423-018-1455-4 · Cited by 22
Raloxifene recovers effects of prenatal immune activation on cognitive task-induced gamma power
Schroeder, A., Nakamura, J., Hudson, M. R., Jones, N. C., Du, X., Sundram, S., & Hill, R. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104448 · Cited by 20
Romero‐Miguel, D., Casquero‐Veiga, M., MacDowell, K. S., Torres-Sánchez, S., Garcia-Partida, J. A., Lamanna‐Rama, N., Romero‐Miranda, A., Berrocoso, E., Leza, J. C., Desco, M., et al. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab036 · Cited by 21
Verdurand, M., Dalton, V. S., Nguyen, V., Grégoire, M., Zahra, D., Wyatt, N. A., Burgess, L., Greguric, I. D., & Zavitsanou, K. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.004 · Cited by 21
Neurodevelopmental insights into circuit dysconnectivity in schizophrenia
Nath, M., Wong, T. P., & Srivastava, L. K. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110047 · Cited by 24
Santana‐Coelho, D., Layne‐Colon, D., Valdespino, R., Ross, C. N., Tardif, S. D., & O’Connor, J. C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.705554 · Cited by 19
Kim, H., Won, H., Im, J., Lee, H., Park, J., Lee, S., Kim, Y., Kim, H., & Kwon, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9417 · Cited by 17
Modeling psychotic disorders: Environment x environment interaction
Murlanova, K., & Pletnikov, M. V. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105310 · Cited by 16
Deane, A. R., Potemkin, N., & Ward, R. D. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112876 · Cited by 15
Rahman, T., Weickert, C. S., Harms, L. R., Meehan, C. L., Schall, U., Todd, J., Hodgson, D. M., Michie, P. T., & Purves-Tyson, T. D. (2020) · Scientific Reports · doi:10.1038/s41598-020-58449-x · Cited by 15
Santis, M. D., Huang, X., & Deng, C. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s158545 · Cited by 12
Ifhar, L. S., Ene, H. M., & Ben‐Shachar, D. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.03.011 · Cited by 13
Casquero‐Veiga, M., Lamanna‐Rama, N., Romero‐Miguel, D., Márquez, H. R., Alcaide, J., Beltrán, M. A. C. S., Nácher, J., Desco, M., & Soto‐Montenegro, M. L. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1022622 · Cited by 12
Al‐Shammari, A. R., Bhardwaj, S. K., Musaelyan, K., Srivastava, L. K., & Szele, F. G. (2018) · Schizophrenia · doi:10.1038/s41537-018-0057-5 · Cited by 12
Chou, S., Davis, C., Jones, S., & Li, M. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.015 · Cited by 11
Zhang, J., Yu, J., Zhang, H., Bilkey, D. K., & Liu, P. (2017) · Synapse · doi:10.1002/syn.22011 · Cited by 12
Prefrontal Cortex Response to Prenatal Insult and Postnatal Opioid Exposure
Rymut, H. E., Rund, L. A., Southey, B. R., Johnson, R. W., Sweedler, J. V., & Rodriguez‐Zas, S. L. (2022) · Genes · doi:10.3390/genes13081371 · Cited by 9
Sørensen, H. J., Foldager, L., Røge, R., Pristed, S. G., Andreasen, J. T., & Nielsen, J. (2013) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2013.854408 · Cited by 10
Felgel-Farnholz, V., Hlusicka, E. B., Edemann-Callesen, H., Garthe, A., Winter, C., & Hadar, R. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114276 · Cited by 9
Nagano, R., Nagano, M., Nakai, A., Takeshita, T., & Suzuki, H. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.051 · Cited by 8
Mutant Mouse Models in Evaluating Novel Approaches to Antipsychotic Treatment
O’Tuathaigh, C. M. P., Desbonnet, L., & Waddington, J. L. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_5 · Cited by 8
Edemann-Callesen, H., Winter, C., & Hadar, R. (2021) · Brain stimulation · doi:10.1016/j.brs.2021.03.018 · Cited by 8
Ashique, S., Paul, D., Debnath, B., Chellappan, D. K., Das, J., Bhui, U., Ramzan, M., Sharma, N., Kumar, B., Sridhar, S. B., et al. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2560658 · Cited by 6
Developmental Immune Activation Models with Relevance to Schizophrenia
Meyer, U. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_2 · Cited by 6
Iwata, K., Noguchi, M., & Shintani, N. (2025) · Biomolecules · doi:10.3390/biom15020184 · Cited by 6
Marks, W. N., Parker, M., & Howland, J. G. (2018) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-812012-5.00007-0 · Cited by 4
Maternal Immune Activation with the Viral Mimetic Poly:IC in Pregnant Rats
Sandini, T. M., Greba, Q., Lins, B. R., & Howland, J. G. (2020) · BIO-PROTOCOL · doi:10.21769/bioprotoc.3817 · Cited by 3
Asor, E., & Ben‐Shachar, D. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i3.294 · Cited by 2
Fattore, L. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00010-9 · Cited by 1
Skubic, S. G., Wynter, Z., Kramer, M. M., & Hales, J. B. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1797607 · Cited by 1
Jung, K., & Kwon, J. (2023) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524923666230905142700 · Cited by 1
Rodent Models of Multiple Environmental Exposures with Relevance to Schizophrenia
Meyer, U. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00021-3 · Cited by 1
Metadata
- Authors
- Piontkewitz, Y., Arad, M., & Weiner, I.
- Affiliations
- Tel Aviv University (IL)
- Corresponding author
- Weiner, Ina
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 62
- Issue
- 3
- Pages
- 1273-1289
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1979322945
- Cited by
- 108
- References
- 271
- Citations by year
- 2026: 2 · 2025: 2 · 2023: 5 · 2022: 7 · 2021: 9 · 2020: 8 · 2019: 7 · 2018: 15 · 2017: 7 · 2016: 12 · 2015: 11 · 2014: 9 · 2013: 5 · 2012: 7
- FWCI
- 0.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- United States-Israel Binational Science Foundation (BSF 2007188)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, neurodevelopmental model, poly(I:C), atypical antipsychotics, clozapine, risperidone, psychosis prevention, hippocampal atrophy, lateral ventricle enlargement, sex differences, attention deficits, prenatal infection, structural neuroimaging, longitudinal brain development, striatum, prefrontal cortex
- MeSH terms
- Age Factors, Animals, Disease Models, Animal, Female, Hippocampus, Humans, Male, Pregnancy, Prenatal Exposure Delayed Effects, Psychotic Disorders, Early Diagnosis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review